Non-pharmacological treatment for chronic obstructive pulmonary disease

Medical Science Monitor

Volumn 9, Issue 12, 2003, Pages

  Clini, Enrico ^a,b,c   Costi, Stefania ^b   Lodi, Silvano ^b   Rossi, Giuseppina ^a,b  

^a Fondazione Villa Pineta   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c Fondazione Villa Pineta   (Italy)

Author keywords

Noninvasive mechanical ventilation; Oxygen; Pulmonary rehabilitation; Thoracic surgery

Indexed keywords

ALTERNATIVE MEDICINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HUMAN; LONG TERM CARE; MEDLINE; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; QUALITY OF LIFE; RESPIRATORY FAILURE; REVIEW; SMOKING CESSATION;

HUMANS; OXYGEN; POSITIVE-PRESSURE RESPIRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING CESSATION;

EID: 17944387883     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Pauwels RA, Buist AS, Calverley PMA et al: on behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med, 2001; 163: 1256-1276
2. Friedman M, Hilleman DE: Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options. Pharmacoeconomics, 2001; 19: 245-254
3. Miravitlles M, Murio C, Guerrero T, Gisbert R, for the DAFNE Study Group. Cost of chronic bronchitis and COPD. A 1-year follow-up study. Chest, 2003; 123: 784-791
4. Miravitlles M, Murio C, Guerrero T, Gisbert R, for the DAFNE Study Group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest, 2002; 121: 1449-1455
5. Faulkner MA, Hilleman DE: The economic impact of chronic obstructive pulmonary disease. Expert Opin Pharmacother, 2002; 3: 219-228
6. Anderson JE, Jorenby DE, Scott WJ et al: Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest, 2002; 121: 932-941
7. Parrott S, Godfrey C, Raw M et al: Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority. Thorax, 1998; 53: S1-S38
8. West R, McNeill A, Raw M: Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax, 2000; 55: 987-999
9. Silagy C, Mant D, Fowler G et al: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, 2000; 3: CD000146
10. Tashkin D, Kanner R, Bailey W et al: Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet, 2001; 357: 1571-1575
11. BTS Statement. Pulmonary rehabilitation. Thorax, 2001; 56: 827-834
12. Lacasse Y, Brosseau L, Milne S et al: Pulmonary rehabilitation for chronic obstructive pulmonary disease (Cochrane review). In: Cochrane Library, issue 3 (Oxford: update software). 2002
13. Garcia-Aymerich J, Farrero E, Felez MA et al, on behalf of the EFRAM investigators: Risk factors of readmissions to hospital for a COPD exacerbation: a prospective study. Thorax, 2003; 58: 100-105
14. Bowen JB, Votto JJ, Thrall RS et al: Functional status and survival following pulmonary rehabilitation. Chest, 2000; 118: 697-703
15. Berry MJ, Rejeski WJ, Adair NE, Zaccaro D: Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med, 1999; 160: 1248-1253
16. Cilione C, Lorenzi C, Dell'Orso D et al: Predictors of change in exercise capacity after comprehensive COPD inpatient rehabilitation. Med Sci Monit, 2002; 8: CR740-CR705
17. Foglio K, Bianchi L, Bruletti G et al: Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J, 1999; 13: 125-132
18. Griffiths TL, Burr ML, Campbell IA et al: Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial [published erratum appears in Lancet, 2000; 355: 1280]. Lancet, 2000; 355: 362-368
19. Griffiths TL, Burr ML, Campbell IA et al: Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial [published erratum appears in Lancet, 2000; 355: 1280]. Lancet, 2000; 355: 362-368
20. Goldstein RS, Gort EH, Stubbing D et al: Randomised controlled trial of respiratory rehabilitation. Lancet, 1994; 344: 1394-1397
21. Hernandez MTE, Rubio TM, Ortega Riuz F et al: Results of a home-based training program for patients with COPD: Chest, 2000; 118: 106-114
22. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med, 2003; 167: 211-277
23. Gosselink R, Decramer M: Muscle training in pulmonary rehabilitation. In: Donner CF, Decramer M (eds). Pulmonary Rehabilitation. Eur Respir Mon, 2000; 13: 99-110
24. ATS Statement. Guidelines for the six-minute walking test. Am J Respir Crit Care Med, 2002; 166: 111-117
25. Singh SJ, Morgan MD et al: Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax, 1992; 47: 1019-1024
26. Lacasse Y, Wong E, Guyatt GH et al: Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet, 1996; 348: 1115-1119
27. Smith K, Cook D, Guyatt GH et al: Respiratory muscle training in chronic airflow limitation: a meta-analysis. Am Rev Respir Dis, 1992; 145: 533-539
28. Lotters F, Van Tol B, Kwakkel G, Gosselink R: Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J, 2002; 20: 570-576
29. Bernard S, Whittom F, Leblanc P et al: Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1999; 159: 896-901
30. Wilson DO, Rogers RM, Wright EC, Anthonisen NR: Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis, 1989; 139: 1435-1438
31. Schols AM, Soeters PB, Dingemans AM et al: Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis, 1993; 147: 1151-1156
32. Schols AM, Slangen J, Volovics L, Wouters EF: Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1998; 157: 1791-1797
33. Efthimiou J, Fleming J, Gomes C, Spiro SG: The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis, 1988; 137: 1075-1082
34. Rogers RM, Donahoe M, Costantino J: Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study. Am Rev Respir Dis, 1992; 146: 1511-1517
35. Whittaker JS, Ryan CF, Buckley PA, Road JD: The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. Am Rev Respir Dis, 1990; 142: 283-288
36. Jones PW, Quirk FH, Baveystock CM: The St. George's Respiratory Questionnaire. Respir Med, 1991; 85 Suppl B: 25-31
37. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, 1992; 30: 473-483
38. Goldstein RS, Gort EH, Guyatt GH, Feeny D: Economic analysis of respiratory rehabilitation. Chest, 1997; 112: 370-379
39. Griffiths TL, Phillips CJ, Davies S et al: Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax, 2001; 56: 779-784
40. Foglio K, Bianchi L, Ambrosino N: It is really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airways obstruction? Chest, 2001; 119: 1696-1704
41. Report of British Research Medical Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet, 1981; i: 681-686
42. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med, 1980; 93: 391-398
43. Tarpy SP, Celli BR: Long-term oxygen therapy. N Engl J Med, 1995; 333: 710-714
44. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med, 1995; 152: S77-S121
45. The European Respiratory Society Task Force. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J, 1995; 8: 1398-1420
46. Snider GL: Enhancement of exercise performance in COPD patients by hyperoxia. Chest, 2002; 122: 1830-1836
47. Petty TL, O'Donohue WJ Jr. Further recommendations for prescribing, reimbursement, technology development, and research in long-term oxygen therapy. Summary of the Fourth Oxygen Consensus Conference, Washington, DC, October 15-16, 1993. Am J Respir Crit Care Med, 1994; 150: 875-877
48. Lightowler JV, Wedzicha JA, Elliott M, Ram FSF: Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbation of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. Br Med J, 2003; 326: 185-189
49. Corrado A, Confalonieri M, Marchese S et al: Iron lung versus mask ventilation in the treatment of acute or chronic respiratory failure in COPD patients. A multi-centre study. Chest, 2002; 121: 189-195
50. ACCP Consensus Conference. Mechanical ventilation beyond the Intensive Care Unit. Chest, 1998; 113: S289-S344
51. Shapiro SH, Ernst P, Gray-Donald K et al: Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease. Lancet, 1992; 340: 1425-1429
52. Meecham-Jones DJ, Paul EA, Jones PW, Wedzicha JA: Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med, 1995; 152: 538-544
53. Clini E, Sturani C, Porta R et al: Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation. Resp Med, 1998; 92; 1215-1222
54. Clini E, Sturani C, Rossi A et al, on behalf of AIPO Study Group on Rehabilitation and Chronic Care: The Italian multi-centre study on non-invasive ventilation in COPD patients. Eur Respir J, 2002; 20: 529-538
55. Wijkstra P, Lacasse Y, Guyatt GH, Goldstein RS: Nocturnal noninvasive positive pressure ventilation for stable chronic obstructive pulmonary disease. The Cochrane Library issue 3 (Oxford: update software), 2002
56. Hughes JA, MacArthur AM, Hutchison DC, Hugh-Jones P: Long term changes in lung function after surgical treatment of bullous emphysema in smokers and ex-smokers. Thorax, 1984; 39: 140-142
57. Mehran RJ, Deslauriers J: Indications for surgery and patient work-up for bullectomy. Chest Surg Clin N Am, 1995; 5: 717-734
58. Laros CD, Gelissen HJ, Bergstein PG et al: Bullectomy for giant bullae in emphysema. J Thorac Cardiovasc Surg, 1986; 91: 63-70
59. Cooper JD, Trulock EP, Triantafillou AN et al: Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg, 1995; 109: 106-116
60. Criner G, Cordova FC, Leyenson V et al: Effect of lung volume reduction surgery on diaphragm strength. Am J Respir Crit Care Med, 1998; 157: 1578-1585
61. Martinez FJ, De Oca MM, Whyte RI et al: Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med, 1997; 155: 1984-1990
62. Cooper JD, Patterson GA, Sundaresan RS et al: Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg, 1996; 112: 1319-1329
63. Russi EW, Stammberger U, Weder W: Lung volume reduction surgery for emphysema. Eur Respir J, 1997; 10: 208-18
64. Geddes D, Davies M, Koyama H et al: Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med, 2000; 343: 239-245
65. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med, 2003; 348: 2059-2073
66. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med, 2001; 345: 1075-1083
67. National Emphysema Treatment Trial Research Group. Cost effectiveness of lung volume reduction therapy. N Engl J Med, 2003; 348: 2092-2102
68. Hosenpud JD, Bennett LE, Keck BM et al: Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet, 1998; 351: 24-27
69. The registry of the ISHLT: official report, 2001. J Heart Lung Transplant, 2000; 19: 909-931
70. Maurer JR, Frost AE, Estenne M et al: International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation, 1998; 66: 951-956
71. Theodore J, Lewiston N: Lung transplantation comes of age [editorial comment]. N Engl J Med, 1990; 322: 772-774
72. Vitulo P, on behalf of Associazione Italiana Pneumologi Ospedalieri (AIPO). AIPO national register on lung transplantation: years 1988-1999. Rass Patol App Respir, 2001; 16: 470-477